183 related articles for article (PubMed ID: 26195859)
1. Invasive candidiasis in non neutropenic critically ill - need for region-specific management guidelines.
Ahmed A; Azim A; Baronia AK; Marak RS; Gurjar M
Indian J Crit Care Med; 2015 Jun; 19(6):333-9. PubMed ID: 26195859
[TBL] [Abstract][Full Text] [Related]
2. EPICO 2.0 project. Development of educational therapeutic recommendations using the DELPHI technique on invasive candidiasis in critically ill adult patients in special situations.
Zaragoza R; Ferrer R; Maseda E; Llinares P; Rodriguez A;
Rev Iberoam Micol; 2014; 31(3):157-75. PubMed ID: 25113990
[TBL] [Abstract][Full Text] [Related]
3. EPICO 2.0 PROJECT. Development of educational therapeutic recommendations using the DELPHI technique on invasive candidiasis in critically ill adult patients in special situations.
Zaragoza R; Ferrer R; Maseda E; Llinares P; Rodríguez A;
Rev Esp Quimioter; 2014 Sep; 27(3):196-212. PubMed ID: 25229375
[TBL] [Abstract][Full Text] [Related]
4. Systematic review on the first line treatment of amphotericin B in critically ill adults with candidemia or invasive candidiasis.
Keane S; Geoghegan P; Povoa P; Nseir S; Rodriguez A; Martin-Loeches I
Expert Rev Anti Infect Ther; 2018 Nov; 16(11):839-847. PubMed ID: 30257597
[TBL] [Abstract][Full Text] [Related]
5. [Management strategies: prophylaxis, empirical and preemptive treatment of established invasive candidiasis in the critically ill non-neutropenic patient].
Del Palacio A; Alhambra A; Cuétara MS
Rev Iberoam Micol; 2006 Mar; 23(1):35-8. PubMed ID: 16499429
[TBL] [Abstract][Full Text] [Related]
6. EPICO 4.0. 'Total quality' in the management of invasive candidiasis in critically ill patients by analysing the integrated process.
Zaragoza R; Ferrer R; Llinares P; Maseda E; Rodríguez A; Grau S; Quindós G;
Rev Iberoam Micol; 2017; 34(3):143-157. PubMed ID: 28734773
[TBL] [Abstract][Full Text] [Related]
7. Management of invasive candidiasis in critically ill patients.
Blot S; Vandewoude K
Drugs; 2004; 64(19):2159-75. PubMed ID: 15456333
[TBL] [Abstract][Full Text] [Related]
8. Candidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy. Study Group of Fungal Infection in the ICU.
Nolla-Salas J; Sitges-Serra A; León-Gil C; Martínez-González J; León-Regidor MA; Ibáñez-Lucía P; Torres-Rodríguez JM
Intensive Care Med; 1997 Jan; 23(1):23-30. PubMed ID: 9037636
[TBL] [Abstract][Full Text] [Related]
9. Candida prophylaxis and therapy in the ICU.
Echeverria PM; Kett DH; Azoulay E
Semin Respir Crit Care Med; 2011 Apr; 32(2):159-73. PubMed ID: 21506052
[TBL] [Abstract][Full Text] [Related]
10. Management of candidaemia and invasive candidiasis in critically ill patients.
Chahoud J; Kanafani ZA; Kanj SS
Int J Antimicrob Agents; 2013 Jun; 42 Suppl():S29-35. PubMed ID: 23664579
[TBL] [Abstract][Full Text] [Related]
11. Antifungal agents for invasive candidiasis in non-neutropenic critically ill adults: What do the guidelines recommend?
Wang Y; McGuire TM; Hollingworth SA; Dong Y; Van Driel ML
Int J Infect Dis; 2019 Dec; 89():137-145. PubMed ID: 31639522
[TBL] [Abstract][Full Text] [Related]
12. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
13. Épico Project. Development of educational recommendations using the DELPHI technique on invasive candidiasis in non-neutropenic critically ill adult patients.
Zaragoza R; Llinares P; Maseda E; Ferrer R; Rodríguez A;
Rev Iberoam Micol; 2013; 30(3):135-49. PubMed ID: 23727234
[TBL] [Abstract][Full Text] [Related]
14. Candidemia and invasive candidiasis: a review of the literature for the burns surgeon.
Ha JF; Italiano CM; Heath CH; Shih S; Rea S; Wood FM
Burns; 2011 Mar; 37(2):181-95. PubMed ID: 20395056
[TBL] [Abstract][Full Text] [Related]
15. [Candidemia and invasive candidiasis approach in critically ill patients: role of the echinocandins].
Almirante B; Garnacho-Montero J; Maseda E; Candel FJ; Grau S; Guinea J; Moreno I; Muñoz P; Ruiz-Santana S
Rev Esp Quimioter; 2017 Oct; 30(5):355-367. PubMed ID: 28945064
[TBL] [Abstract][Full Text] [Related]
16. Preventing invasive candida infections. Where could we do better?
Eggimann P; Que YA; Revelly JP; Pagani JL
J Hosp Infect; 2015 Apr; 89(4):302-8. PubMed ID: 25592726
[TBL] [Abstract][Full Text] [Related]
17. Early diagnosis of candidiasis in non-neutropenic critically ill patients.
Ibàñez-Nolla J; Nolla-Salas M; León MA; García F; Marrugat J; Soria G; Díaz RM; Torres-Rodríguez JM
J Infect; 2004 Feb; 48(2):181-92. PubMed ID: 14720495
[TBL] [Abstract][Full Text] [Related]
18. EPICO PROJECT. Development of educational recommendations using the DELPHI technique on invasive candidiasis in non- neutropenic critically ill adult patients.
Epico Project Group
Rev Esp Quimioter; 2013 Jun; 26(2):131-50. PubMed ID: 23817652
[TBL] [Abstract][Full Text] [Related]
19. [Épico project: Development of educational recommendations using the DELPHI technique on invasive candidiasis in non-neutropenic critically ill adult patients. Grupo Proyecto Épico].
Zaragoza R; Llinares P; Maseda E; Ferrer R; Rodríguez A;
Rev Iberoam Micol; 2013; 30(3 Suppl 1):135-49. PubMed ID: 23764554
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of candidemia and associated candida subtypes following severe sepsis in non-neutropenic critically ill patients.
Kashiha A; Setayesh N; Panahi Y; Ahmadi A; Soltany-Rezaee-Rad M; Najafi A; Rouini MR; Namipashaki A; Sahebkar A; Mojtahedzadeh M
Acta Biomed; 2018 Jun; 89(2):193-202. PubMed ID: 29957751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
